Transplantation, AutologousMultiple MyelomaHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationMelphalanTransplantation ConditioningPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsBone MarrowCombined Modality TherapyTreatment OutcomeBone Marrow CellsRemission InductionSalvage TherapyDisease-Free SurvivalCyclophosphamideStem CellsLymphoma, Non-HodgkinHematopoietic Stem Cell MobilizationRecurrenceBone Marrow PurgingEtoposideHodgkin DiseaseGraft vs Host DiseaseCarmustineHematopoietic Stem CellsMyeloablative AgonistsCytarabineSurvival RateLiver TransplantationWhole-Body IrradiationSurvival AnalysisBoronic AcidsHematologic NeoplasmsGraft SurvivalVincristineThalidomidePyrazinesAntigens, CD34Retrospective StudiesBusulfanDexamethasoneThiotepaPrognosisDoxorubicinGranulocyte Colony-Stimulating FactorFollow-Up StudiesAmyloidosisKidney TransplantationTime FactorsAntineoplastic Agents, AlkylatingLeukapheresisLymphoma, Mantle-CellAntineoplastic AgentsBone and BonesCell TransplantationAntibodies, Monoclonal, Murine-DerivedLymphomaPrednisoneTransplantation ChimeraTissue DonorsMesenchymal Stem Cell TransplantationAutograftsNeoplasm, ResidualLymphoma, FollicularLeukemia, Myeloid, AcuteLymphoma, T-Cell, PeripheralIfosfamideInduction ChemotherapyHematopoiesisMyelodysplastic SyndromesLeukemia, Plasma CellCord Blood Stem Cell TransplantationImmunosuppressive AgentsHeart TransplantationCell DifferentiationMaintenance ChemotherapyPodophyllotoxinLeukemiaBlood Component RemovalAntibodies, MonoclonalLung TransplantationIdarubicinMyeloma ProteinsLymphoma, Large B-Cell, DiffuseProspective StudiesHistocompatibility TestingCells, CulturedFeasibility StudiesLymphoma, B-CellFlow CytometryTransplantation ImmunologyGraft RejectionBone Marrow DiseasesPlasma CellsNeoplasm Recurrence, LocalGraft vs Tumor EffectLeukemia, Myeloid